DMD, dystrophin, 1756

N. diseases: 484; N. variants: 345
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE In this study, we performed BMD measurement combined with vertebral fracture assessment (VFA) by DXA for the postmenopausal women receiving the first bone densitometry and studied the impact of VFA on the diagnosis of osteoporosis. 31352490 2020
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Altogether, 126 postmenopausal women belonging to four different groups were included: healthy (n=42), low BMD and no vertebral fractures (n=39), vertebral fractures and low BMD without a treatment (n=26), or receiving a treatment for osteoporosis (n=19). 31669252 2020
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Using the T-score approach our aims were to: i) investigate the effects of oral nitrogen-containing bisphosphonates on bone balance and turnover in postmenopausal women with osteoporosis and ii) determine the relationship of the change in bone balance and turnover with the change in BMD at the lumbar spine and total hip. 31740343 2020
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE To compare associations of current and past self-reported bone-specific physical activity, and current accelerometer-determined physical activity (PA), with bone structure (bone mineral density [BMD] and microarchitecture) in postmenopausal women with osteopenia or osteoporosis. 31720706 2020
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE BMD measurements and kidney function for risk prediction were also evaluated; women were categorized by both reduced kidney function (stages 3-5) and osteoporosis status. 31754754 2020
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 AlteredExpression disease BEFREE The objectives of this study are to assess the correlation between BMD and serum lipid levels, to determine independent variables associated with osteoporosis and osteopenia in men and postmenopausal women with type 2 diabetes (T2D). 30235494 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE The diagnosis of osteoporosis is intimately linked with the imaging and quantification of bone and BMD. 31189982 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE The purpose of our study is to examine the association between LTL, and BMD and osteoporosis among an elderly Chinese population. 31025211 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE This prospective study examined the effects of once-weekly teriparatide treatment on the serum levels of sclerostin, osteocalcin, and bone formation markers as well as BMD of the lumbar spine and femoral neck in 32 postmenopausal women with osteoporosis. 30573396 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE A number of studies investigated the distribution of BMD values and the prevalence of osteoporosis in China, but their findings varied. 31067339 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE The medical history, anthropometric data, lumbar and femoral BMD (DXA) [considering osteoporosis (OP): T-score ⩽-2.5], TBS (considering degraded microarchitecture: <1.230) and dorsolumbar X-ray [to assess vertebral fractures (VF)] were evaluated. 31628810 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Retrospective, observational cohort study using Swedish national health register data and BMD data from osteoporosis clinics. 30963310 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE This study included 128 patients with osteoporosis (BMD T-score -3.2±1.9; range, -5.4 to -2.5) who underwent spinal decompression and instrumentation with a polymethylmethacrylate-augmented bone cement-injectable cannulated pedicle screw. 31188908 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE The cost-effectiveness of preventive alendronate therapy for postmenopausal women with osteopenia or osteoporosis using GC is sensitive to age, BMD, GC dose, and the presence of previous fracture. 30610244 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 AlteredExpression disease BEFREE The levels of OC were significantly different in women with osteopenia and osteoporosis (ANOVA, p < .0001) compared to women with normal BMD. 30537473 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE Faecal microbiota profiles were determined from 181 individuals with osteopenia (n = 61) or osteoporosis (n = 60), and an age- and gender-matched group with normal BMD (n = 60). 31378815 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Since BMD was proved to be highly heritable, based on a comprehensive genome-wide meta-analysis that reported 63 BMD-related single nucleotide polymorphisms (SNPs), we aim to unravel the overall genetic risk for decreased BMD and osteoporosis in African-American women. 31786628 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Despite normal areal BMD values assessed by dual-energy X-ray absorptiometry and no family history of osteoporosis, the patient demonstrated low lumbar spine trabecular bone score, as well as low peripheral trabecular volumetric BMD and deterioration of trabecular microarchitecture assessed by high-resolution peripheral quantitative computed tomography. 31273389 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE As he continued to run over the following 2 years, his mileage threshold to fracture steadily and rapidly decreased until he was diagnosed with severe osteoporosis (lumbar spine BMD Z-score of -3.2). 30972028 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE A total 24 texture features demonstrated statistically significant differences between normal BMD and osteoporosis in the left sphenoid and a total of 31 texture features in the left condyle. 31153568 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE Data from human diseases or dysfunctions identified 19 genes whose mutation was associated with human BMD: 9 genes each for human height and osteoporosis; 4 genes each for human osteoarthritis (OA) and fracture risk; and 2 genes each for adolescent idiopathic scoliosis (AIS), periodontitis, osteosarcoma growth, and tooth development. 31646011 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE We divided our population into 5 groups with different phenotypes characterizing the severity of the disease and/or the severity of bone involvement: 1 - Normal BMD and body mass index (BMI): recovery from AN; 2 - Osteopenia (-2<Z-score<-1) and BMI>17kg/m<sup>2</sup>; 3 - Osteopenia and BMI≤17kg/m<sup>2</sup>; 4 - Osteoporosis (Z-score≤-2) and BMI>17kg/m<sup>2</sup>; 5 - Osteoporosis and BMI≤17kg/m<sup>2</sup>. 29653285 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE This study estimated normative BMD and TBS reference data for women aged 20-70 in Sri Lanka and the effect of local reference data on the diagnosis of osteoporosis among postmenopausal women. 31432256 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE BMD (classified according to the WHO criteria for osteoporosis) of the hip and lumbar spine, the VFx (classified as a Genant score >1/>20% height loss), and radiological progression (modified stoke ankylosing spondylitis spinal score [mSASSS]) scores were obtained at baseline and at 4 years of TNFi treatment.Overall, 135 AS patients were included. 30690799 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 AlteredExpression disease BEFREE A once-weekly pill containing risedronate and cholecalciferol had the equivalent antiresorptive efficacy on BMD compared with risedronate alone and improved 25(OH) D serum levels after 12 months of treatment without significant adverse events in Korean patients with osteoporosis. 31820121 2019